Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Cellular Microbiology|February 21, 2013
VEGF receptor-1 involvement in pericyte loss induced by Escherichia coli in an in vitro model of blood brain barrierMario Salmeri, Carla Motta, Carmelina D Anfuso, et al.
Investigative Ophthalmology & Visual Science|October 28, 2016
Molecular Mechanisms Mediating Antiangiogenic Action of the Urokinase Receptor-Derived Peptide UPARANT in Human Retinal Endothelial CellsCarla Motta, Gabriella Lupo, Dario Rusciano, et al.
Frontiers in Pharmacology|April 20, 2017
Gabapentin Attenuates Ocular Inflammation: <i>In vitro</i> and <i>In vivo</i> StudiesCarmelina D Anfuso, Melania Olivieri, Annamaria Fidilio, et al.
Pharmaceutics|June 2, 2021
Ferulic Acid-Loaded Polymeric Nanoparticles for Potential Ocular DeliveryAlessia Romeo, Teresa Musumeci, Claudia Carbone, et al.
Biochimica Et Biophysica Acta|November 30, 2002
Cytosolic phospholipase A2 mediates arachidonoyl phospholipid hydrolysis in immortalized rat brain endothelial cells stimulated by oxidized LDLGabriella Lupo, Giovanna Assero, Carmelina D Anfuso, et al.
International Journal of Molecular Sciences|August 14, 2025
Breaking Barriers: The Role of the Bone Marrow Microenvironment in Multiple Myeloma ProgressionAleksandra Agafonova, Chiara Prinzi, Angela Trovato Salinaro, et al.
Cancers|September 11, 2019
A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain TumoursIrina Naletova, Lorena Maria Cucci, Floriana D'Angeli, et al.
Journal of Lipid Research|February 3, 2007
Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCalpha and the MAPK/ERK cascadeCarmelina Daniela Anfuso, Gabriella Lupo, Loriana Romeo, et al.
Biochemical Pharmacology|June 10, 2015
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathwayGiovanni Giurdanella, Carmelina Daniela Anfuso, Melania Olivieri, et al.
European Journal of Pharmacology|May 3, 2015
PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cellsCarla Motta, Floriana D'Angeli, Marina Scalia, et al.
Pageof 9